
Bistroriq D 30mg/20mg Capsule SR
Marketer
Riqfame Critical Care Private Limited
Salt Composition
Domperidone (30mg) + Rabeprazole (20mg)
Overview Bistroriq D 30mg/20mg Capsule SR
Gastro-esophageal reflux disease (GERD) is effectively managed with the combined-action capsule, Bistroriq D 30mg/20mg SR. This medication alleviates common GERD symptoms like heartburn, abdominal pain, and irritation by neutralizing stomach acid and facilitating gas expulsion. Bistroriq D 30mg/20mg SR capsules are administered on an empty stomach, following your physician's prescribed dosage and duration. Treatment length depends on your individual response and condition. Premature discontinuation may lead to symptom recurrence and disease exacerbation. Comprehensive disclosure of all other medications to your healthcare provider is essential, as interactions are possible. Common, typically transient side effects include diarrhea, abdominal pain, dry mouth, headache, flatulence, and fatigue. Report any concerning side effects immediately. Due to potential dizziness and drowsiness, refrain from operating machinery or engaging in activities requiring alertness until the medication's effects are known. Alcohol consumption should be avoided due to its potential to increase sleepiness. Lifestyle adjustments, such as consuming cool milk and avoiding caffeinated beverages, spicy foods, and chocolate, can enhance treatment efficacy. Prior to commencing treatment, disclose any kidney or liver conditions, as well as pregnancy, pregnancy planning, or breastfeeding status, to your doctor.
Primary Ingredients of Bistroriq D 30mg/20mg Capsule SR
No text provided to rephrase.
Uses of Bistroriq D 30mg/20mg Capsule SR
Managing gastroesophageal reflux and peptic ulcers.
Major Benefits of Bistroriq D 30mg/20mg Capsule SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Bistroriq D 30mg/20mg Capsule SR whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.
Common Side effects of Bistroriq D 30mg/20mg Capsule SR:
- Cough
- Headache
- Diarrhea
- Dizziness
- Inflammation of the nose
- Abdominal pain
- Vomiting
- Weakness
- Nasal congestion (stuffy nose)
- Insomnia (difficulty in sleeping)
- Fundic gland polyps
- Nausea
- Constipation
- Flatulence
- Back pain
- Pharyngitis
How to use Bistroriq D 30mg/20mg Capsule SR:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the entire capsule without chewing, crushing, or breaking it. Bistroriq D 30mg/20mg Sustained-Release Capsules should be taken on an empty stomach.
How Bistroriq D 30mg/20mg Capsule SR works:
Bistroriq D 30mg/20mg sustained-release capsules contain Domperidone and Rabeprazole, two medications working synergistically. Domperidone, a prokinetic agent, enhances gastrointestinal motility, facilitating smoother food passage through the stomach. Rabeprazole, a proton pump inhibitor (PPI), decreases stomach acid production, thus alleviating acid reflux symptoms and heartburn.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when combining Bistroriq D 30mg/20mg SR Capsules with alcohol. Seek medical advice before doing so.
PregnancyCONSULT YOUR DOCTOR
The extended-release Bistroriq D 30mg/20mg capsule may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Bistroriq D 30mg/20mg capsules are likely not safe for breastfeeding mothers. Available human data indicates potential transfer to breast milk with consequent infant risk.
DrivingUNSAFE
Taking Bistroriq D 30mg/20mg sustained-release capsules might reduce attentiveness, impair vision, and cause drowsiness or dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with impaired kidney function should use Bistroriq D 30mg/20mg sustained-release capsules cautiously. Dosage modification of Bistroriq D 30mg/20mg sustained-release capsules may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Bistroriq D 30mg/20mg SR capsules cautiously, potentially requiring dosage modification. Consult a physician. Bistroriq D 30mg/20mg SR capsules are contraindicated in individuals with moderate to severe hepatic dysfunction.
What if you forget to take Bistroriq D 30mg/20mg Capsule SR :
Should you forget to take a Bistroriq D 30mg/20mg sustained-release capsule, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Bistroriq D 30mg/20mg Capsule SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Gastrointestinal system |
